Low dosage liposomal amphotericin B in the treatment of Candida infections in critically ill patients

J Chemother. 2011 Aug;23(4):242. doi: 10.1179/joc.2011.23.4.242.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Candidiasis / drug therapy*
  • Critical Illness
  • Humans
  • Middle Aged
  • Pilot Projects
  • Treatment Outcome

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Amphotericin B